TOCILIZUMAB vs TOFACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TOCILIZUMAB vs TOFACITINIB: Safety Overview
| Metric | TOCILIZUMAB | TOFACITINIB |
|---|---|---|
| Total FAERS Reports | 98,443 | 155,647 |
| Deaths Reported | 9,543 | 7,847 |
| Death Rate | 9.7% | 5.0% |
| Hospitalizations | 24,039 | 21,976 |
| Average Patient Age | 52.2 yrs | 57.6 yrs |
| % Female Patients | 84.5% | 81.6% |
| FDA Approval Date | N/A | Aug 19, 2021 |
| Manufacturer | CELLTRION USA, Inc. | Pfizer Laboratories Div Pfizer Inc |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |